Table 3.
Events in 6‐year Follow‐up in Groups With Different MmiR‐199a Level*
| Event | Total (n=176) | Low MmiR‐199a Level (n=88) | High Mmir‐199a Level (n=88) | P Value |
|---|---|---|---|---|
| Cardiovascular mortality | 13 (7.4) | 8 (9.1) | 5 (5.7) | 0.387 |
| All‐cause mortality | 27 (15.3) | 13 (14.8) | 14 (15.9) | 0.834 |
| Nonfatal myocardial infarction | 6 (3.4) | 4 (4.5) | 2 (2.3) | 0.682 |
| PCI | 33 (18.8) | 22 (25) | 11 (12.5) | 0.034 |
| CABG | 10 (5.7) | 7 (8) | 3 (3.4) | 0.193 |
| Revascularization | 43 (24.4) | 29 (33) | 14 (15.9) | 0.009 |
| First MACE | 55 (31.3) | 35 (39.8) | 20 (22.7) | 0.015 |
Data are shown as number (percentage). CABG indicates coronary artery bypass graft; MACE, major adverse cardiovascular event; MmiR, microRNA in circulating microvesicles; PCI, percutaneous coronary intervention.
*
According to the median of MmiR‐199a.